Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: Further development of a potential model of autism spectrum disorders

Journal of Neurochemistry

Volumn 113, Issue 2, 2010, Pages 515-529

  MacFabe, Derrick F ^a   Thomas, Raymond H ^a   Foley, Kelly A ^a   Mepham, Jennifer R ^a   Tichenoff, Lisa J ^a   Possmayer, Fred ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Carnitine; Clostridia; Gap junctions; Lipids; Mitochondria; Movement disorder; Short chain fatty acids

Indexed keywords

ACYLCARNITINE; BUTYRIC ACID; CARDIOLIPIN; CARNITINE; INOSITOL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMALOGEN; PROPIONIC ACID; SPHINGOMYELIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR CHANGE; CONTROLLED STUDY; FATTY ACID METABOLISM; LIPID COMPOSITION; LOCOMOTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CARNITINE; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMATOGRAPHY, THIN LAYER; DISEASE MODELS, ANIMAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; PHOSPHOLIPIDS; PROPIONIC ACIDS; RATS; RATS, LONG-EVANS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEREOTYPED BEHAVIOR;

CLOSTRIDIA; RODENTIA;

EID: 77949667960     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06614.x     Document Type: Article

References (81)

1. Amminger G. P., Berger G. E., Schafer M. R., Klier C., Friedrich M. H. Feucht M. (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol. Psychiatry 61, 551 553.
2. Arndt T. L., Stodgell C. J. Rodier P. M. (2005) The teratology of autism. Int. J. Dev. Neurosci. 23, 189 199.
3. Ashwood P. Van de Water J. (2004) Is autism an autoimmune disease? Autoimmun. Rev. 3, 557 562.
4. Aureli T., Di Cocco M. E., Capuani G., Ricciolini R., Manetti C., Miccheli A. Conti F. (2000) Effect of long-term feeding with acetyl-l-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy. Neurochem. Res. 25, 395 399.
5. Bell J. G., Sargent J. R., Tocher D. R. Dick J. R. (2000) Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot. Essent. Fatty Acids 63, 21 25.
6. Bell J. G., MacKinlay E. E., Dick J. R., MacDonald D. J., Boyle R. M. Glen A. C. (2004) Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids 71, 201 204.
7. Bertrand J., Mars A., Boyle C., Bove F., Yeargin-Allsopp M. Decoufle P. (2001) Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108, 1155 1161.
8. Bicalho B., David F., Rumplel K., Kindt E. Sandra P. (2008) Creating a fatty acid methyl ester database for lipid profiling in a single drop of human blood using high resolution capillary gas chromatography and mass spectrometry. J. Chromatogr. A 1211, 120 128.
9. Brass E. P., Fennessey P. V. Miller L. V. (1986) Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. Biochem. J. 236, 131 136.
10. Brock M. Buckel W. (2004) On the mechanism of action of the antifungal agent propionate. Eur. J. Biochem. 271, 3227 3241.
11. Bu B., Ashwood P., Harvey D., King I. B., Water J. V. Jin L. W. (2006) Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot. Essent. Fatty Acids 74, 215 221.
12. Calabrese V. Rizza V. (1999) Formation of propionate after short-term ethanol treatment and its interaction with the carnitine pool in rat. Alcohol 19, 169 176.
13. Cannizzaro C., Monastero R., Vacca M. Martire M. (2003) [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions. Neurochem. Int. 43, 9 17.
14. Champeil-Potokar G., Chaumontet C., Guesnet P., Lavialle M. Denis I. (2006) Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur. J. Neurosci. 24, 3084 3090.
15. Chauhan A. Chauhan V. (2006) Oxidative stress in autism. Pathophysiology. 13, 171 181.
16. Chauhan A., Chauhan V., Brown W. T. Cohen I. (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci. 75, 2539 2549.
17. Chow S. C., Sisfontes L., Bjorkhem I. Jondal M. (1989) Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 24, 700 704.
18. Clarke J. T. Clark-Taylor B. E. (2004) Is autism a disorder of fatty acid metabolism? Possible dysfunction of metochondrial beta oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 62, 970 975.
19. Coulter D. L. (1991) Carnitine, valproate, and toxicity. J. Child Neurol. 6, 7 14.
20. Crawley J. N. (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10, 248 258.
21. Cyr D., Giguere R., Giguere Y. Lemieux B. (2000) Determination of urinary acylcarnitines: a complementary aid for the high-risk screening of several organic acidurias using a simple and reliable GC/MS-based method. Clin. Biochem. 33, 151 155.
22. DeCastro M., Nankova B. B., Shah P., Patel P., Mally P. V., Mishra R. La Gamma E. F. (2005) Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Res. Mol. Brain Res. 142, 28 38.
23. Edwards R., Peet M., Shay J. Horrobin D. (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48, 149 155.
24. Fallon J. (2005) Could one of the most widely prescribed antibiotics amoxicillin/clavulanate «augmentin» be a risk factor for autism? Med. Hypotheses 64, 312 315.
25. Farooqui A. A. Horrocks L. A. (2001) Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7, 232 245.
26. Fatemi S. H., Cuadra A. E., El Fakahany E. E., Sidwell R. W. Thuras P. (2000) Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11, 1493 1496.
27. Fatemi S. H., Pearce D. A., Brooks A. I. Sidwell R. W. (2005) Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57, 91 99.
28. Filipek P. A., Juranek J., Nguyen M. T., Cummings C. Gargus J. J. (2004) Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34, 615 623.
29. Filosa J. A., Dean J. B. Putnam R. W. (2002) Role of intracellular and extracellular pH in the chemosensitive response of rat locus coeruleus neurones. J. Physiol. 541, 493 509.
30. Finegold S. M., Molitoris D., Song Y. et al. (2002a) Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35, S6 S16.
31. Finegold S. M., Song Y. Liu C. (2002b) Taxonomy-general comments and update on taxonomy of Clostridia and Anaerobic cocci. Anaerobe 8, 283 285.
32. 2+ oscillation in neuron-astrocyte cocultures in vitro. Neurochem. Int. 33, 41 49.
33. Hara H., Haga S., Aoyama Y. Kiriyama S. (1999) Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J. Nutr. 129, 942 948.
34. Hartig C. (2008) Rapid identification of fatty acid methyl esters using a multidimensional gas chromatography-mass spectrometry database. J. Chromatogr. A 1177, 159 169.
35. Herbert M. R., Russo J. P., Yang S., Roohi J., Blaxill M., Kahler S. G., Cremer L. Hatchwell E. (2006) Autism and environmental genomics. Neurotoxicology 27, 671 684.
36. Horrobin D. F. Bennett C. N. (1999) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 60, 141 167.
37. Horvath K., Papadimitriou J. C., Rabsztyn A., Drachenberg C. Tildon J. T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135, 559 563.
38. Hu V. W., Frank B. C., Heine S., Lee N. H. Quackenbush J. (2006) Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics 7, 118.
39. Ingram J. L., Peckham S. M., Tisdale B. Rodier P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319 324.
40. James S. J., Melnyk S., Jernigan S. et al. (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med Genet. B Neuropsychiatr. Genet. 141, 947 956.
41. Juszczak G. R. Swiergiel A. H. (2009) Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 181 198.
42. Jyonouchi H., Sun S. Itokazu N. (2002) Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46, 76 84.
43. Kamitani W., Ono E., Yoshino S. et al. (2003) Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc. Natl Acad. Sci. U S A 100, 8969 8974.
44. Kidd P. M. (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12, 207 227.
45. Kiebish M. A., Han X., Cheng H., Chuang J. H. Seyfried T. N. (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 49, 2545 2556.
46. Le Poul E., Loison C., Struyf S. et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481 25489.
47. MacFabe D. F., Cain D. P., Rodriguez-Capote K., Franklin A. E., Hoffman J. E., Boon F., Taylor A. R., Kavaliers M. Ossenkopp K. P. (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176, 149 169.
48. MacFabe D. F., Rodriguez-Capote K., Hoffman J. E. et al. (2008) A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am. J. Biochem. Biotech. 4, 146 166.
49. Maurer M. H., Canis M., Kuschinsky W. Duelli R. (2004) Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci. Lett. 355, 105 108.
50. Meguid N. A., Atta H. M., Gouda A. S. Khalil R. O. (2008) Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin. Biochem. 41, 1044 1048.
51. Moore H. Grace A. A. (2002) A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology 27, 980 992.
52. Morris J. S., Coombes K. R., Koomen J., Baggerly K. A. Kobayashi R. (2005) Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics 21, 1764 1775.
53. Nakao S., Moriya Y., Furuyama S., Niederman R. Sugiya H. (1998) Propionic acid stimulates superoxide generation in human neutrophils. Cell Biol. Int. 22, 331 337.
54. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M. Okado N. (2002) Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52, 576 579.
55. Parab S., Nankova B. B. La Gamma E. F. (2007) Differential regulation of the tyrosine hydroxylase and enkephalin neuropeptide transmitter genes in rat PC12 cells by short chain fatty acids: concentration-dependent effects on transcription and RNA stability. Brain Res. 1132, 42 50.
56. Pastural E., Ritchie S., Lu Y., Jin W., Kavianpour A., Khine Su-Myat K., Heath D., Wood P. L., Fisk M. Goodenowe D. B. (2009) Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot. Essent. Fatty Acids 81, 253 264.
57. Paxinos G. Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney; Montreal.
58. Remblier C., Pontcharraud R., Tallineau C., Piriou A. Huguet F. (1999) Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxidative mechanisms. Brain Res. 837, 22 28.
59. Richardson A. J. (2004) Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 70, 383 390.
60. Roe R. C., Millington D. S., Maltby D. A., Bohan T. P. Hoppel C. L. (1984) l-Carnitine enhances excretion of propoinyl coenzyme A as propionylcarnitine in propoinic acidemia. J. Clin. Invest. 73, 1785 1788.
61. Rorig B., Klausa G. Sutor B. (1996) Intracellular acidification reduced gap junction coupling between immature rat neocortical pyramidal neurones. J. Physiol. 490 (pt-1 31 49.
62. Rouach N., Avignone E., Meme W., Koulakoff A., Venance L., Blomstrand F. Giaume C. (2002) Gap junctions and connexin expression in the normal and pathological central nervous system. Biol. Cell 94, 457 475.
63. Schulpis K. H., Karikas G. A., Tjamouranis J., Regoutas S. Tsakiris S. (2001) Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia 42, 1359 1362.
64. Severson C. A., Wang W., Pieribone V. A., Dohle C. I. Richerson G. B. (2003) Midbrain serotonergic neurons are central pH chemoreceptors. Nat. Neurosci. 6, 1139 1140.
65. Seyfried T. N. Mukherjee P. (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr. Metab (Lond) 2, 30.
66. Sherma J. Fried B. (2003) Handbook of Thin Layer Chromatography, pp. 635 991. Marcel Dekker Inc., New York.
67. Shultz S. R., MacFabe D. F., Ossenkopp K. P., Scratch S., Whelan J., Taylor R. Cain D. P. (2008) Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 54, 901 911.
68. Shultz S. R., MacFabe D. F., Martin S., Jackson J., Taylor R., Boon F., Ossenkopp K. P. Cain D. P. (2009) Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav. Brain Res. 200, 33 41.
69. Simopoulos A. P. (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60, 502 507.
70. Sliwinski S., Croonenberghs J., Christophe A., Deboutte D. Maes M. (2006) Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuro. Endocrinol. Lett. 27, 465 471.
71. Smith I. D., Sutton M. A. Beninger R. J. (1997) Rotational bias in intact rats following intrastriatal injections of dopaminergic drugs. Pharmacol. Biochem. Behav. 58, 431 441.
72. Suzuki K., Nagao K., Tokunaga J., Katayama N. Uyeda M. (1996) Inhibition of DNA methyltransferase by microbial inhibitors and fatty acids. J. Enzyme Inhib. 10, 271 280.
73. Vancassel S., Durand G., Barthelemy C., Lejeune B., Martineau J., Guilloteau D., Andres C. Chalon S. (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 65, 1 7.
74. Vargas D. L., Nascimbene C., Krishnan C., Zimmerman A. W. Pardo C. A. (2004) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67 81.
75. Volkmar F. R., Lord C., Bailey A., Schultz R. T. Klin A. (2004) Autism and pervasive developmental disorders. J. Child Psychol. Psychiatry 45, 135 170.
76. Wagner A. K., Bayir H., Ren D., Puccio A., Zafonte R. D. Kochanek P. M. (2004) Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J. Neurotrauma 21, 125 136.
77. Wajner M., Latini A., Wyse A. T. Dutra-Filho C. S. (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 27, 427 448.
78. Wiest M. M., German J. B., Harvey D. J., Watkins S. M. Hertz-Picciotto I. (2009) Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot. Essent. Fatty Acids 80, 221 227.
79. Wu K., Wasterlain C., Sachs L. Siekevitz P. (1990) Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex. Proc. Natl Acad. Sci. U S A 87, 5298 5302.
80. Zaffanello M., Zamboni G., Fontana E., Zoccante L. Tato L. (2003) A case of partial biotinidase deficiency associated with autism. Child Neuropsychol. 9, 184 188.
81. Zerrate M. C., Pletnikov M., Connors S. L., Vargas D. L., Seidler F. J., Zimmerman A. W., Slotkin T. A. Pardo C. A. (2007) Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J. Pharmacol. Exp. Ther. 322, 16 22.